ONE STAGE CHRONOMETRIC FVIII ASSAY OR TWO STAGE CHROMOGENIC FVIII ASSAY TO DIAGNOSE HAEMOPHILIA A?

被引：0
|
作者：
Marchand, K. [1 ]
Benoit, R. [1 ]
Martin, M. [2 ]
Fretigny, M. [3 ]
Toussaint-Hacquard, M. [1 ]
Frotscher, B. [2 ]
机构：
[1] Univ Hosp Nancy, Lab Haematol, Vandoeuvre Les Nancy, France
[2] Univ Hosp Nancy, Haemophilia Treatment Ctr, Vandoeuvre Les Nancy, France
[3] Univ Hosp Lyon, Lab Genet, Lyon, France
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO012
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN ONE-STAGE AND CHROMOGENIC FVIII ASSAY DISCREPANCIES AND GENETIC ANALYSIS OF FVIII GENE IN PATIENTS WITH NON-SEVERE HAEMOPHILIA A
    Obregon, J.
    Calvo Villas, J. M.
    Marco Rico, A.
    Herrero Martin, S.
    Urena, L. E.
    Lopez Jaime, F. J.
    Diaz Jordan, B.
    Garcia Diaz, C.
    Jurado Herrera, S.
    Perez Gonzalez, N. F.
    Garcia Candel, F.
    Marco Vera, P.
    Fernandez Bello, I.
    Montano Brioso, A.
    HAEMOPHILIA, 2023, 29 : 26 - 27
  • [2] One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype
    Cid, A. R.
    Calabuig, M.
    Cortina, V.
    Casana, P.
    Haya, S.
    Moret, A.
    Cabrera, N.
    Aznar, J. A.
    HAEMOPHILIA, 2008, 14 (05) : 1049 - 1054
  • [3] FVIII OS/CS ratios for select novel recombinant fviii replacement products measured in four FDA approved FVIII one-stage clot assay systems and one chromogenic assay
    Tiefenbacher, S.
    Robinson, M. M.
    Ross, E. L.
    Williams, P. T.
    Cogswell, C. E.
    Wham, T. L.
    Chow, G. K.
    Adcock, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 836 - 836
  • [4] Multi-centre Australia wide study comparing FVIII assay variation in haemophilia A patients receiving two different recombinant FVIII products using the one stage and chromogenic assays
    Khoo, T. L.
    Kershaw, G.
    Matthews, S.
    Clare, W.
    Bowyer, A.
    Kitchen, S.
    Dunkley, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 669 - 669
  • [5] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assay
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Hrachovinova, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 833 - 833
  • [6] FVIII assay discrepancy - hemophilia A variants escaping the two-stage assay
    Brondke, H.
    Herbiniaux, U.
    Oldenburg, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 54 - 54
  • [7] Higher FVIII:C measured by chromogenic substrate assay than by one-stage assay is associated with silent hemophilic arthropathy
    Ogawa, Mika
    Suzuki, Nobuaki
    Takahashi, Nobunori
    Tamura, Shogo
    Suzuki, Atsuo
    Suzuki, Sachiko
    Hattori, Yuua
    Kakihara, Misaki
    Kanematsu, Takeshi
    Kojima, Toshihisa
    Katsumi, Akira
    Hayakawa, Fumihiko
    Kojima, Tetsuhito
    Ishiguro, Naoki
    Kiyoi, Hitoshi
    Matsushita, Tadashi
    THROMBOSIS RESEARCH, 2020, 188 : 103 - 105
  • [8] PREANALYTIC HEAT INACTIVATION CHANGES THE FVIII INHIBITOR WITH ONE STAGE AND CHROMOGENIC FVIII ASSAYS
    Gilles, Ivy Pike
    Larson, Reid
    Campbell, Joseph
    Tange, Julie
    Chen, Dong
    Heikal, Nahla
    Pruthi, Rajiv
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 142 - 142
  • [9] Comparison of the behavior of different factor VIII products measured with the chromogenic factor VIII activity assay and the FVIII one stage clotting assay
    Van Duren, C.
    Schutgens, R.
    Polenewen, R.
    Brons, P.
    Laros-Van Gorkom, B.
    Van Heerde, W. L.
    HAEMOPHILIA, 2014, 20 : 64 - 64
  • [10] Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
    Kihlberg, Kristina
    Strandberg, Karin
    Ljung, Rolf
    Berntorp, Erik
    Astermark, Jan
    HAEMOPHILIA, 2016, 22 : 70 - 70
12345